20th Annual Conference on Vaccine Research (2017)

Wednesday April 26

0 results found.

Type here to filter the list

Wednesday, April 26, 2017
7:00 AM - 7:45 AM

Dr. Richard J. Duma Meet the Experts Breakfast Sessions
7:00 AM - 7:45 AM

Biology of Antibody-Enhanced Dengue Disease: Evidence of Increased Risk After CYDTDV Vaccination

Favorite

Scott B. Halstead, MD – International Vaccine Institute ### 78363###Featured Presenter
7:00 AM - 7:45 AM

Clinical Development of Synthetic DNA Vaccines: Advances in the Technology

Favorite

David B. Weiner, PhD – Wistar Institute ### 307030###Featured Presenter
7:00 AM - 7:45 AM

Development and Approval Pathways for Vaccines to Prevent Emerging Infectious Diseases: FDA Regulatory Perspective

Favorite

Marion F. Gruber, PhD – US Food and Drug Administration ### 78362###Featured Presenter
7:00 AM - 7:45 AM

How to Get Published: Writing Effective Journal Articles

Favorite

Gregory A. Poland, MD – Mayo Clinic and Foundation ### 78369###Featured Presenter
7:00 AM - 7:45 AM

Maximizing Benefit and Minimizing Risk for the World's First Licensed Dengue Vaccine: CYD-TDV

Favorite

Timothy P. Endy, MD, MPH – State University of New York, Upstate Medical University ### 79041###Featured Presenter
7:00 AM - 7:45 AM

Post-licensure Vaccine Safety Monitoring

Favorite

Tom T. Shimabukuro, MD, MPH, MBA – Centers for Disease Control and Prevention ### 142883###Featured Presenter
7:00 AM - 8:00 AM

Continental Breakfast
7:00 AM - 8:00 AM

Continental Breakfast

Favorite
8:00 AM - 10:00 AM

Symposium 5: Vaccine Innovations
8:10 AM - 8:30 AM

S5-1 - Clinical Development of Synthetic DNA Vaccines: Advances in the Technology

Favorite

David B. Weiner, PhD – Wistar Institute ### 307030###Presenter
8:30 AM - 8:50 AM

S5-2 - mRNA-based Vaccines Against HIV and Other Pathogens

Favorite

Drew Weissman, MD, PhD – University of Pennsylvania ### 307032###Presenter
8:50 AM - 9:10 AM

S5-3 - Structure-based Immunogen Design for Flavivirus Vaccines

Favorite

Felix A. Rey, PhD – Institut Pasteur ### 307031###Presenter
9:10 AM - 9:30 AM

S5-4 - Recoding Structural Glycoprotein E2 in Classical Swine Fever Virus (CSFV) and Its Potential Use as a Vaccine Candidate

Favorite

Lauro Velazquez, DVM, MSc – Plum Island Animal Disease Center ### 316812###Presenter
10:00 AM - 10:30 AM

Coffee Break
10:00 AM - 10:30 AM

Coffee Break

Favorite
10:30 AM - 12:30 PM

Symposium 6: Evaluating Vaccine Safety During Public Health Emergencies
10:40 AM - 11:10 AM

S6-1 - Systematic Observational Method for Narcolepsy and Influenza Immunization Assessment (Somnia): Risk of Narcolepsy Following Adjuvanted 2009 H1N1 Influenza Vaccines

Favorite

Tom T. Shimabukuro, MD, MPH, MBA – Centers for Disease Control and Prevention ### 142883###Presenter
11:10 AM - 11:40 AM

S6-2 - Maintaining Public Confidence in Vaccines During a Pandemic

Favorite

Daniel A. Salmon, PhD – Johns Hopkins Bloomberg School of Public Health ### 316814###Presenter
11:40 AM - 12:10 PM

S6-3 - Monitoring Influenza Vaccine Safety in Sentinel/Prism

Favorite

Katherine Yih, PhD, MPH – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 316815###Presenter
12:30 PM - 1:30 PM

Lunch (on your own)
12:30 PM - 1:30 PM

Lunch (on Your Own)

Favorite
1:30 PM - 2:30 PM

Closing Keynote: Vaccines to Fight Emerging Infectious Diseases: Use of Novel Platform Technologies (non-CME)
1:30 PM - 2:30 PM

Closing Keynote: Vaccines to Fight Emerging Infectious Diseases: Use of Novel Platform Technologies (non-CME)

Favorite

Phyllis A. Arthur, MBA – Biotechnology Innovation Organization ### 318682###Moderator @@@ Marc-André D'Aoust, PhD – Medicago ### 367442###Panelist @@@ David B. Weiner, PhD – Wistar Institute ### 307030###Panelist @@@ Jeffrey B. Ulmer, PhD – GSK Vaccines ### 367443###Panelist @@@ Christopher R. Heery, MD – Bavarian Nordic A/S ### 367441###Panelist
2:45 PM - 4:45 PM

Technical Tour to GSK (Pre-Registration Required)
2:45 PM - 4:45 PM

Technical Tour to GSK (Pre-Registration Required)
Location: Offsite

Favorite